| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 2,702 | $131.70 | $355,853.40 | -6.2% | -18.6% | -71.8% | |
| Jul 2, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 3,794 | $180.15 | $683,496.10 | - | +5.3% | -16.8% | |
| Jul 2, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 3,794 | $180.15 | $683,496.10 | - | +5.3% | -16.8% | |
| Jul 1, 2021 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 35,000 | $33.66 | $1,178,068.50 | -10.4% | -14.0% | -48.4% | |
| Jul 1, 2021 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 7,784 | $123.43 | $960,779.12 | -1.0% | -26.1% | -66.8% | |
| Jul 1, 2021 | TTOO T2 Biosystems, Inc. | McDonough John | Director | Sell | 18,182 | $1.16 | $21,091.12 | -3.4% | - | - | |
| Jul 1, 2021 | TTOO T2 Biosystems, Inc. | Cumming John W | Director | Sell | 18,182 | $1.16 | $21,091.12 | -26.3% | - | - | |
| Jun 29, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 4,926 | $181.11 | $892,147.86 | - | +7.6% | -15.5% | |
| Jun 29, 2021 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 10,559 | $130.00 | $1,372,670.00 | -100% | -1.6% | -67.1% | |
| Jun 29, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 4,926 | $181.11 | $892,147.86 | - | +7.6% | -15.5% | |
| Jun 29, 2021 | XGN Exagen Inc. | Tullis James L L73 | Director | Sell | 25,000 | $15.28 | $382,110.05 | -0.5% | -5.6% | -62.5% | |
| Jun 28, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 6,812 | $32.39 | $220,608.32 | -1.0% | +4.1% | -41.1% | |
| Jun 28, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 1,381 | $117.57 | $162,366.10 | -5.6% | -1.3% | -67.7% | |
| Jun 28, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 685 | $117.57 | $80,536.41 | -1.4% | -1.3% | -67.7% | |
| Jun 28, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,604 | $117.57 | $306,155.93 | -3.4% | -1.3% | -67.7% | |
| Jun 28, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 914 | $117.57 | $107,460.26 | -0.9% | -1.3% | -67.7% | |
| Jun 28, 2021 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 22,422 | $95.50 | $2,141,308.02 | -5.3% | -34.9% | -77.0% | |
| Jun 28, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,740 | $121.12 | $210,757.47 | - | -1.3% | -67.7% | |
| Jun 28, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 19,071 | $180.81 | $3,448,312.51 | -0.2% | +5.3% | -17.9% | |
| Jun 28, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 19,071 | $180.81 | $3,448,312.51 | -0.2% | +5.3% | -17.9% | |
| Jun 25, 2021 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 83,372 | $31.96 | $2,664,215.76 | -9.8% | +6.6% | -41.9% | |
| Jun 25, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Executive Chair | Sell | 10,000 | $95.29 | $952,922.80 | -1.3% | -28.0% | -74.5% | |
| Jun 24, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 10,000 | $74.93 | $749,286.00 | -1.1% | +0.2% | -68.3% | |
| Jun 24, 2021 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 10,602 | $95.31 | $1,010,513.73 | -6.9% | -30.5% | -75.0% | |
| Jun 23, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 1,837 | $180.79 | $332,111.23 | - | +5.2% | -14.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.